ArticleMolecules (Basel, Switzerland)2026
Antioxidant and Anti-Osteoclastogenic Potential of Olive Oil Dregs Extracts.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The agri-food industry generates substantial amounts of waste, which are increasingly regarded as valuable resources within the framework of the circular economy. Among the recoverable bioactive molecules, phenolic compounds are of particular interest for nutraceutical and biomedical applications. Olive oil production by-products, such as olive oil dregs (OOD), represent a rich source of polyphenols, especially hydroxytyrosol (3,4-DHPEA). In this study, we investigated the in vitro biological properties of OOD extracts obtained through methanolic or eco-friendly aqueous extraction methods, both characterized by a high 3,4-DHPEA content. The antioxidant potential of the extracts was evaluated together with their activity in murine peritoneal macrophages, while their ability to counteract osteoclastogenesis was assessed using RAW 264.7 cells stimulated with receptor activator of nuclear factor kappa-B ligand (RANKL). Our results demonstrated that both extracts showed a total antioxidant effect and significantly reduced intracellular reactive oxygen species (ROS) levels. Notably, this antioxidant activity was accompanied by a marked inhibition of RANKL-induced osteoclast formation, as evidenced by a reduction in tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells together with fewer mature osteoclasts displaying well-structured F-actin rings and bone-resorbing activity as demonstrated by the pit formation assay. Taken together, these findings suggest that OOD extract, through its dual antioxidant and anti-osteoclastogenic properties, may represent a promising strategy for the prevention of inflammation-driven pathological bone loss.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.